Literature DB >> 20925403

Computational analysis of HIV-1 protease protein binding pockets.

Gene M Ko1, A Srinivas Reddy, Sunil Kumar, Barbara A Bailey, Rajni Garg.   

Abstract

Mutations that arise in HIV-1 protease after exposure to various HIV-1 protease inhibitors have proved to be a difficult aspect in the treatment of HIV. Mutations in the binding pocket of the protease can prevent the protease inhibitor from binding to the protein effectively. In the present study, the crystal structures of 68 HIV-1 proteases complexed with one of the nine FDA approved protease inhibitors from the Protein Data Bank (PDB) were analyzed by (a) identifying the mutational changes with the aid of a developed mutation map and (b) correlating the structure of the binding pockets with the complexed inhibitors. The mutations of each crystal structure were identified by comparing the amino acid sequence of each structure against the HIV-1 wild-type strain HXB2. These mutations were visually presented in the form of a mutation map to analyze mutation patterns corresponding to each protease inhibitor. The crystal structure mutation patterns of each inhibitor (in vitro) were compared against the mutation patterns observed in in vivo data. The in vitro mutation patterns were found to be representative of most of the major in vivo mutations. We then performed a data mining analysis of the binding pockets from each crystal structure in terms of their chemical descriptors to identify important structural features of the HIV-1 protease protein with respect to the binding conformation of the HIV-1 protease inhibitors. Data mining analysis is performed using several classification techniques: Random Forest (RF), linear discriminant analysis (LDA), and logistic regression (LR). We developed two hybrid models, RF-LDA and RF-LR. Random Forest is used as a feature selection proxy, reducing the descriptor space to a few of the most relevant descriptors determined by the classifier. These descriptors are then used to develop the subsequent LDA, LR, and hierarchical classification models. Clustering analysis of the binding pockets using the selected descriptors used to produce the optimal classification models reveals conformational similarities of the ligands in each cluster. This study provides important information in understanding the structural features of HIV-1 protease which cannot be studied by other existing in vivo genomic data sets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20925403      PMCID: PMC2981608          DOI: 10.1021/ci100200u

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  40 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Classification of multidrug-resistance reversal agents using structure-based descriptors and linear discriminant analysis.

Authors:  G A Bakken; P C Jurs
Journal:  J Med Chem       Date:  2000-11-16       Impact factor: 7.446

3.  Comparative Quantitative Structureminus signActivity Relationship Studies on Anti-HIV Drugs.

Authors:  Rajni Garg; Satya P. Gupta; Hua Gao; Mekapati Suresh Babu; Asim Kumar Debnath; Corwin Hansch
Journal:  Chem Rev       Date:  1999-12-08       Impact factor: 60.622

Review 4.  HIV-1 protease inhibitors: a comparative QSAR analysis.

Authors:  Alka Kurup; Suresh B Mekapati; Rajni Garg; Corwin Hansch
Journal:  Curr Med Chem       Date:  2003-09       Impact factor: 4.530

5.  Hydrophobicity of amino acid residues in globular proteins.

Authors:  G D Rose; A R Geselowitz; G J Lesser; R H Lee; M H Zehfus
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

6.  Cation-pi interactions in structural biology.

Authors:  J P Gallivan; D A Dougherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 7.  The packaging and maturation of the HIV-1 Pol proteins.

Authors:  Melissa Hill; Gilda Tachedjian; Johnson Mak
Journal:  Curr HIV Res       Date:  2005-01       Impact factor: 1.581

8.  Ensembles of Bayesian-regularized genetic neural networks for modeling of acetylcholinesterase inhibition by huprines.

Authors:  Michael Fernández; Julio Caballero
Journal:  Chem Biol Drug Des       Date:  2006-10       Impact factor: 2.817

9.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

Review 10.  Fosamprenavir: a review of its use in the management of antiretroviral therapy-naive patients with HIV infection.

Authors:  Therese M Chapman; Greg L Plosker; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more
  4 in total

1.  Application of Radial Basis Function Network Tool for Correlation of CD4+ Count with Plasma Viral Load in HIV-Seropositive Individuals.

Authors:  Arnaw Kishore; Sumana M Neelambike
Journal:  J Clin Diagn Res       Date:  2016-04-01

2.  Prediction of ligand binding using an approach designed to accommodate diversity in protein-ligand interactions.

Authors:  Lorraine Marsh
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

3.  Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints.

Authors:  Joke Snoeck; Jacques Fellay; István Bartha; Daniel C Douek; Amalio Telenti
Journal:  Retrovirology       Date:  2011-11-01       Impact factor: 4.602

4.  The sense behind retroviral anti-sense transcription.

Authors:  Mamneet Manghera; Alycia Magnusson; Renée N Douville
Journal:  Virol J       Date:  2017-01-14       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.